Know your World in Just 60 Words!
Read news in 1 minute
Hot Topics
Select the content to hear the Audio

Added on : 2021-08-02 15:20:14

A recent study by the Indian Council of Medical Research reveals that Bharat Biotech's Covaxin is effective against the rampant Delta Plus variant of COVID-19. Covaxin was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) National Institute of Virology (NIV). Earlier, Bharat Biotech had said that Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

Covid 19 Update

Headlines

Good News

politics

India

World

Copyright © 2019 Newz Viewz | Created by Communicators and Developed by Seawind Solution Pvt. Ltd.